Position in CGEN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,096,576
-$14,404 QoQ
Shares Held
512,419
-1.8% QoQ
Ownership
0.541%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 82 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in CGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $7,273,624,947 across 342 Biotechnology names. CGEN ranks #200 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,875,937 | $564,713,315 | |
| 2 | MRNA |
Moderna, Inc.
|
7,193,530 | $503,762,905 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
6,252,342 | $495,748,197 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
656,124 | $409,119,558 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,722,185 | $351,708,338 | |
| 6 | EXEL |
Exelixis, Inc.
|
4,209,861 | $229,058,537 | |
| 7 | INCY |
Incyte Corp
|
2,003,559 | $227,123,448 | |
| 8 | ARGX |
Argenx SE
|
185,638 | $172,229,367 |
All Filings in CGEN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,096,576 | 512,419 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,110,980 | 521,587 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $465,032 | 303,943 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $290,876 | 197,875 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $318,523 | 178,946 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $341,339 | 233,794 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $82,684 | 54,042 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $134,271 | 74,183 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $34,082 | 20,287 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $262,752 | 101,842 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $256,279 | 129,434 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $273,539 | 294,128 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $448,344 | 393,285 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $441,667 | 630,953 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $597,345 | 829,647 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,001,918 | 1,518,059 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $934,797 | 505,296 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,060,278 | 329,279 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,755,376 | 408,227 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,149,122 | 359,987 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $137,050 | 16,552 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,737,095 | 202,223 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||